Inovio Pharmaceuticals, Inc. (GBMB.F)
Chart Events
Performance Outlook
| Previous Close | 0.3600 |
| Open | 0.3420 |
| Bid | 0.3460 x 30000 |
| Ask | 0.3570 x 30000 |
| Day's Range | 0.3420 - 0.3420 |
| 52 Week Range | 0.3140 - 1.7836 |
| Volume | |
| Avg. Volume | 2,087 |
| Market Cap | 96.139M |
| Beta (5Y Monthly) | 0.99 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.5800 |
| Earnings Date | Feb 28, 2024 - Mar 04, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 13.22 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for GBMB.F
Related Research
InvestorPlaceThe 3 Most Undervalued Biotech Stocks to Buy: November 2023
These companies in the biotechnology sector are doing incredible work and achieving wonderful developments. The result is not not only growth and profit for the companies, but they are also offering excellent and efficient solutions for the health of each one of us. Personally, the biotechnology sector is one of my favorite sectors because it is always growing and developing. If you are as interested in these companies as I am, here are 3 undervalued biotech stocks to take a look at. Inovio (INO
Insider MonkeyInovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript November 9, 2023 Inovio Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.13 EPS, expectations were $-0.13. Operator: Good afternoon, ladies and gentlemen and welcome to the Inovio Third Quarter 2023 Financial Results Conference Call. At this time all lines are in a listen-only […]
Motley FoolInovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript
Good afternoon, and thank you for joining the Inovio 2023 third quarter conference call. Joining me on today's call are Dr. Jackie Shea, president and CEO; Dr. Michael Sumner, chief medical officer; Mr.
